Dr. Reddy's launches authorized generic version of NitroDur Transdermal Infusion System

15 Apr 2020 Evaluate

Dr. Reddy's Laboratories has launched authorized generic version of NitroDur (nitroglycerin) Transdermal Infusion System. The combined market for all Nitrogylcerin Transdermal Patch products had US sales of around $14.7 million MAT for the most recent twelve months ending in January 2020 according to IQVIA Health.

The company’s Nitroglycerin Transdermal Infusion System is available in four dosage strengths: 0.1 mg/hr, 0.2 mg/hr, 0.4 mg/hr, and 0.6 mg/hr, each in a box of 30 count. NitroDur is a trademark of USpharma.

Dr. Reddy's Laboratories is a multinational pharmaceutical company based in Hyderabad, Telangana in India. It manufactures and markets a wide range of pharmaceuticals in India and overseas

Dr. Reddys Lab Share Price

1208.30 -16.00 (-1.31%)
29-Jan-2026 14:48 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1594.10
Dr. Reddys Lab 1208.30
Cipla 1324.55
Zydus Lifesciences 889.55
Lupin 2131.05
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×